CLINICAL_TRIALS
trial_result
· 2021-07-09
Clinical Trial Update: Trial of Oxaloacetate in Alzheimer's Disease (TOAD) [Phase 1]
Summary
Phase 1 trial update for Oxaloacetate in Alzheimer's disease (TOAD) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Russell Swerdlow | Conditions: Alzheimer's Disease (AD) | Phase 1 | Status: COMPLETED | Results posted: 2021-07-09